- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 32.74M sh |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $741.93M |
| Long Term Debt | Q1 2025 · Dec 29, 2024 | $741.65M |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $44.01M |
| Cash And Equivalents | Q1 2025 · Dec 29, 2024 | $37.96M |
| Stockholders Equity | Q1 2025 · Mar 30, 2025 | −$431.93M |
| Stockholders Equity | Q1 2025 · Dec 29, 2024 | −$429.53M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $282.9M |
| Current Liabilities | Q1 2025 · Dec 29, 2024 | $277.96M |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $1.31B |
| Total Liabilities | Q1 2025 · Dec 29, 2024 | $1.3B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $242.12M |
| Current Assets | Q1 2025 · Dec 29, 2024 | $230.61M |
| Total Assets | Q1 2025 · Mar 30, 2025 | $898.09M |
| Total Assets | Q1 2025 · Dec 29, 2024 | $888.95M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 32.91M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $15.07M |
| Capex | Q1 2025 · Mar 31, 2024 | $13.06M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $11.99M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.44 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.45 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $57.88M |
| Net Income | Q1 2025 · Mar 31, 2024 | $14.64M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $33.72M |
| Revenue | Q1 2025 · Mar 31, 2024 | $513.92M |